SPEAR UltraDetect™ pTau231
Spear Bio | Catalog # SPR90009
Spear Assays
Successive Proximity Extension Amplification Reaction (SPEAR) technology overcomes the limitations of conventional proximity extension assays and dramatically reduces transient noise to achieve ultra-sensitive biomarker detection. This technology delivers rapid, precise, and reproducible results with minimal sample volume. SPEAR immunoassays employ a simple and scalable workflow, easily adopted by any lab utilizing standard qPCR.
Key Product Details
Sample Type & Volume Required Per Well
Sensitivity
Assay Range
Product Summary for SPEAR UltraDetect™ pTau231
Product Specifications
Reactivity
Specificity
Cross-reactivity
Interference
Sample Values
| Sample Type (donors) | Mean Conc. (range) | Above LLoD % | Above LLoQ % |
| EDTA plasma (34 donors) | 2.13 pg/mL (0.304 - 6.41) | 100% | 97% |
| CSF* (11 donors) | 52.2 pg/mL (29.3 - 120) | 100% | 100% |
Precision
EDTA Plasma
| Intra-Assay Precision | Inter-Assay Precision | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 4 | 5 | 6 | 1 | 2 | 3 | 4 | 5 | 6 |
| n | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Mean (pg/mL) | 2.20 | 4.95 | 9.45 | 18.2 | 36.4 | 68.4 | 2.20 | 4.95 | 9.45 | 18.2 | 36.4 | 68.4 |
| Standard Deviation | ||||||||||||
| CV% | 4.9 | 2.6 | 2.9 | 1.9 | 2.0 | 2.6 | 8.2 | 5.8 | 7.2 | 6.5 | 4.8 | 6.3 |
Recovery for SPEAR UltraDetect™ pTau231
Recovery
| Sample Type | Average % Recovery | Range % |
|---|---|---|
| EDTA Plasma (n=3) | 103 | 79-111 |
Linearity
To assess the accuracy of the assay, EDTA Plasma from apparently healthy donors were spiked with CSF and serially diluted 2x to 32x above assay MRD. Percent recovery was calculated as the sample concentration at higher dilution divded by the sample concentration at MRD.
Preparation and Storage
Shipping
Stability & Storage
Background: Tau
The Tau protein is a microtubule-associated protein expressed primarily in axons of central nervous system neurons. Tau is also detected in oligodendrocytes, the somatodendritic compartment within neurons, and some non-neuronal tissues. In healthy neurons, Tau promotes the assembly and stabilization of microtubules along with other MAP proteins, especially MAP1B. It is believed that other proteins can compensate for loss of Tau protein function as Tau knockout mice are viable and show no signs of neurodegeneration. There are multiple isoforms of Tau created by alternative splicing of exons 2, 3, and 10. And Tau protein is heavily phosphorylated throughout the protein mostly occurring on Ser-Pro and Thr-Pro motifs. Several kinases and phosphatases regulate the phosphorylation state of Tau.
Hyperphosphorylation of Tau is an underlying cause of tauopathies, a group of neurodegenerative diseases that are characterized by accumulation of misfolded Tau protein into neurofibrillary tangles (NFT). Alzheimer’s disease and Parkinson’s disease are two tauopathies. Hyperphosphorylated Tau protein exhibits lower affinity for microtubules resulting in destabilization of the cytoskeleton and a reduction in axonal transport. When Tau protein gets hyperphosphorylated, it promotes misfolding and oligomerization into NFT ultimately causing neuronal impairment and cell death.
Long Name
Alternate Names
Gene Symbol
Additional Tau Products
Product Documents for SPEAR UltraDetect™ pTau231
Product Specific Notices for SPEAR UltraDetect™ pTau231
For research use only